12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/18/26 20:17
9/16/26
ADPTHealthBioPrdBiological Products, (No DiagLo FrancisWAOChief Pe6M.dm10,40017.220604233D
9/18/26 20:17
9/16/26
ADPTHealthBioPrdBiological Products, (No DiagLo FrancisWAOChief Pe6S.dm-10,40017.220-604233D
9/17/26 18:50
9/15/26
ADPTHealthBioPrdBiological Products, (No DiagBobulsky SusanWAOChief Co5S-26424.060-11406D
8/28/26 17:50
8/26/26
ADPTHealthBioPrdBiological Products, (No DiagOwen Katey EinterzWAD1S-25026.000-1079D
8/20/26 17:55
8/18/26
ADPTHealthBioPrdBiological Products, (No DiagHershberg RobertWAD2M.d84318.46046999%47D
8/20/26 17:55
8/18/26
ADPTHealthBioPrdBiological Products, (No DiagHershberg RobertWAD2S.d-84318.460-4647D
8/19/26 20:15
8/17/26
ADPTHealthBioPrdBiological Products, (No DiagRobins Chad MWADOCEO,CB2M.dm18,81215.6801,2001222,181D
8/19/26 20:15
8/17/26
ADPTHealthBioPrdBiological Products, (No DiagRobins Chad MWADOCEO,CB2S.dm-18,81215.680-1,2002,181D
8/19/26 20:07
8/17/26
ADPTHealthBioPrdBiological Products, (No DiagNeupert Peter MWAD2M.d3,23123.130140131D
8/19/26 20:07
8/17/26
ADPTHealthBioPrdBiological Products, (No DiagNeupert Peter MWAD2S.d-3,23123.130-140131D
7/23/26 19:34
7/21/26
ADPTHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief Sc3M.d21,14718.1801,1631,020D
7/23/26 19:34
7/21/26
ADPTHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief Sc3S.d-21,14718.180-1,1631,020D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact